Aligos Therapeutics (ALGS) Ending Cash Balance (2019 - 2026)
Aligos Therapeutics' Ending Cash Balance came in at $31.74 million for Q3 2026, down 24.5% from $42.06 million a year earlier but up 4.3% from the prior quarter.
Aligos Therapeutics (ALGS) Ending Cash Balance (2019 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics' Ending Cash Balance was $18.41 million, down 50.4% from FY2024.
- Ending Cash Balance carries a five-year compound annual growth rate of -39.2% (FY2020 to FY2025).
- Going back by year, Ending Cash Balance was $37.11 million in FY2024 (-72.7%), $135.77 million in FY2023 (+66.7%), $81.46 million in FY2022 (-56.4%) and $186.98 million in FY2021 (-15.4%).
- The five-year range for quarterly Ending Cash Balance is $18.41 million (Q4 2025) to $186.98 million (Q4 2021).
- Year-over-year, Ending Cash Balance increased in three of the last eight quarters, with growth averaging 2.3%.
- The fastest year-over-year change in Ending Cash Balance over five years came in Q1 2025 (growth of 203.2%), and the weakest in Q4 2024 (a decline of 72.7%).
- Business Quant data shows ALGS's Ending Cash Balance at $30.42 million (Q2 2026), $30.15 million (Q1 2026) and $18.41 million (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | 31.74 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 31.74 Mn |
| Jun 30, 2026 | 30.42 Mn |
| Mar 31, 2026 | 30.15 Mn |
| Dec 31, 2025 | 18.41 Mn |
| Sep 30, 2025 | 42.06 Mn |
| Jun 30, 2025 | 18.77 Mn |
| Mar 31, 2025 | 73.87 Mn |
| Dec 31, 2024 | 37.11 Mn |
| Sep 30, 2024 | 35.44 Mn |
| Jun 30, 2024 | 45.15 Mn |
| Mar 31, 2024 | 24.37 Mn |
| Dec 31, 2023 | 135.77 Mn |
| Sep 30, 2023 | 70.50 Mn |
| Jun 30, 2023 | 90.87 Mn |
| Mar 31, 2023 | 79.07 Mn |
| Dec 31, 2022 | 81.46 Mn |
| Sep 30, 2022 | 86.52 Mn |
| Jun 30, 2022 | 71.19 Mn |
| Mar 31, 2022 | 106.12 Mn |
| Dec 31, 2021 | 186.98 Mn |
Aligos Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();